ARTICLE | Company News
Genmab, J&J deal
November 10, 2014 8:00 AM UTC
Genmab will receive a $10 million milestone payment from Johnson & Johnson's Janssen Biotech Inc. unit under an August 2012 deal granting the unit exclusive, worldwide rights to daratumumab. The miles...